Merck & Co., Schering-Plough Accused of Fraud | DC Metro Area Medical Malpractice Law Blog

Posted by: Salvatore J. Zambri, Esquire

Bloomberg News reports that “Merck & Co. and Schering-Plough Corp. were sued by a Pennsylvania fund for active and retired state employees over claims they misled consumers into paying too much for prescriptions of Zetia [ezetimibe] and Vytorin cholesterol pills.”  The Pennsylvania Employees Benefit Trust Fund alleges in a complaint that “the companies have known for years — and failed to make public — that Zetia doesn’t reduce fatty arterial plaques that can cause heart attacks and strokes.”  The reports comments that two studies last year showed that “the pills may work no better at unclogging arteries than does an older, cheaper medicine called simvastatin.” Nevertheless, the companies allegedly withheld the the finding and “used false and deceptive marketing techniques claiming Vytorin was more efficacious than and just as safe as the much cheaper generic,” according to the report.

If a defective product has caused you or a loved one to suffer, you owe it to yourself to get help. Contact the legal team at Regan Zambri and Long PLLC for a free consultation on your product liability case.

About the Author

Patrick M. Regan, Esq.

Patrick Regan is a board certified personal injury lawyer and a founding partner at Regan Zambri Long. His practice is devoted to helping those who suffered catastrophic injuries in car accidents, truck accidents, Metro accidents, and medical malpractice. Over his nearly 40-year career, Patrick has obtained some of the most significant jury verdicts in the history of Washington, DC on behalf of injured victims. Patrick is licensed to practice law in Washington, DC, Virginia, and Maryland. He received his B.A. at Hamilton College and his J.D. at the Columbus School of Law at the Catholic University of America.